A Novel D2/D3/5-HT7 Antagonist Shows Promise in Acute Schizophrenia
June 18, 2026
Amisulpride is a benzamide-based antipsychotic that is not approved...
Read More
Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Depression
June 16, 2026
ECT is among the most effective treatments for treatment-resistant ...
Read More
Poor Mood Response to Oral Contraceptives Linked to Higher Risk of Peripartum and Premenstrual Depression
June 9, 2026
Depressive episodes occurring at times of reproductive hormone chan...
Read More
Mirtazapine Demonstrates Efficacy in Routine Care for Methamphetamine Use Disorder
June 5, 2026
Methamphetamine use disorder affects about 7.4 million people world...
Read More
Supporting Better PTSD Care Through Clinical Education
June 4, 2026
Throughout PTSD Awareness Month, we remain committed to supporting ...
Read More
Benzodiazepine Use Linked to Reduced Risk of Catatonia Recurrence
June 3, 2026
Nearly half of catatonia patients experience recurrent episodes, wh...
Read More
Beyond the Myths: Reassessing Lithium’s Risks and Benefits
May 26, 2026
Lithium has long been a cornerstone treatment for bipolar disorder,...
Read More
World Schizophrenia Day: Education & Resources
May 24, 2026
World Schizophrenia Day is observed each year on May 24 to raise aw...
Read More
Chatbots Reinforce Users’ Psychotic Ideations
May 17, 2026
Large language model (LLM) chatbots such as ChatGPT are increasingl...
Read More
Parkinson’s Protein α-Synuclein Linked to Accelerated Tau Accumulation in Women
May 15, 2026
In Alzheimer’s disease and dementia with Lewy bodies, women exhibit...
Read More
Children’s Mental Health Awareness Day
May 7, 2026
At NEI, we are committed to supporting the clinicians who care for ...
Read More
Choosing an Adjunctive Antipsychotic for Major Depressive Disorder
May 6, 2026
Most patients with major depressive disorder (MDD) do not achieve f...
Read More